SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	0 Months Ended		3 Months Ended					3 Months Ended																		12 Months Ended	3 Months Ended
	Mar. 14, 2014	May 22, 2013	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2013	May 30, 2012	Mar. 31, 2014 Africa [Member]	Mar. 31, 2013 Africa [Member]	Mar. 31, 2014 Asia [Member]	Mar. 31, 2013 Asia [Member]	Mar. 31, 2014 Europe [Member]	Mar. 31, 2013 Europe [Member]	Mar. 31, 2014 North America [Member]	Mar. 31, 2013 North America [Member]	Mar. 31, 2014 South America [Member]	Mar. 31, 2013 South America [Member]	Mar. 31, 2014 Cost of Goods Sold [Member]	Mar. 31, 2013 Cost of Goods Sold [Member]	Mar. 31, 2014 Research and Development Expense [Member]	Mar. 31, 2013 Research and Development Expense [Member]	Mar. 31, 2014 Selling, General and Administrative Expenses [Member]	Mar. 31, 2013 Selling, General and Administrative Expenses [Member]	Mar. 31, 2014 Stock Options [Member]	Mar. 31, 2013 Stock Options [Member]	Dec. 31, 2012 Stock Options [Member]	Mar. 31, 2014 1999 Stock Option Plan [Member] Stock Options [Member]	Mar. 31, 2014 2008 Stock Incentive Plan [Member] Stock Options [Member]	Dec. 31, 2008 2008 Stock Incentive Plan [Member] Stock Options [Member]
Basis of Presentation [Abstract]
Reverse stock split conversion ratio							1-for-8
Common stock outstanding before reverse stock split (in shares)							63,967,263
Common stock outstanding after reverse stock split (in shares)							7,995,918
Inventories [Abstract]
Raw materials			$ 1,859,948			$ 1,710,627
Work in process			642,487			464,481
Finished goods			1,102,168			1,013,618
Inventories			3,604,603			3,188,726
Earnings (Loss) Per Share [Abstract]
Reverse stock split conversion ratio							1-for-8
Common stock outstanding before reverse stock split (in shares)							63,967,263
Common stock outstanding after reverse stock split (in shares)							7,995,918
Summary of weighted average shares used for computation of basic and diluted earnings per share [Abstract]
Basic (in shares)			9,339,181		8,062,984
Diluted (in shares)			9,339,181		8,699,209
Summary of common share equivalent basis, used in diluted per share computations [Abstract]
1999 and 2008 Plan Stock Options (in shares)			0		636,225
Options and warrants excluded from calculation of diluted per common share equivalent because the effect would have been anti-dilutive (in shares)			675,363		86,516
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized under the plan (in shares)																											375,000	750,000	625,000
Number of stock options outstanding under the plan (in shares)																								758,481			46,875	504,738
Maximum period of stock option issuance after adoption of SOP																											10 years
Increase in number of shares authorized (in shares)																												125,000
Number of stock options exercised under the plan (in shares)																								147,917				245,262
Options or shares still available to be issued (in shares)																												0
Weighted average estimated grant-date fair value of stock options granted (in dollars per share)			$ 3.42		$ 4.00
Assumptions made in calculating fair values of options [Abstract]
Expected term																								6 years 3 months 18 days	4 years 9 months 18 days
Expected volatility (in hundredths)																								96.10%	100.91%
Expected dividend yield (in hundredths)																								0.00%	0.00%
Risk-free interest rate (in hundredths)																								1.52%	0.56%
Stock options, number of shares [Roll forward]
Outstanding, beginning of period (in shares)																								656,398
Granted (in shares)	250,000	5,000	30,000	5,000	30,000																			250,000
Exercised (in shares)																								(147,917)				(245,262)
Forfeited/expired/cancelled (in shares)																								0
Outstanding, end of period (in shares)																								758,481			46,875	504,738
Exercisable, end of period (in shares)																								374,070
Stock options, outstanding, weighted average exercise price per share [Roll Forward]
Outstanding, beginning of period (in dollars per share)																								$ 2.57
Granted (in dollars per share)	$ 3.4163			$ 4.50																				$ 3.42
Exercised (in dollars per share)																								$ 1.04
Forfeited/expired/cancelled (in dollars per share)																								$ 0.00
Outstanding, end of period (in dollars per share)																								$ 3.04
Exercisable, end of period (in dollars per share)																								$ 2.37
Stock options, additional disclosure [Abstract]
Outstanding, weighted average remaining contractual term, beginning of period																								3 years 5 months 26 days		1 year 7 months 24 days
Outstanding, weighted average remaining contractual term, end of period																								3 years 5 months 26 days		1 year 7 months 24 days
Exercisable, weighted average remaining contractual term, end of period																								1 year 4 months 2 days
Outstanding, aggregate intrinsic value, beginning of period																								801,888
Outstanding, aggregate intrinsic value, end of period																								552,981
Exercisable, aggregate intrinsic value, end of period																								520,468
Net unrecognized compensation cost																								786,188
Weighted average period for recognition of net unrecognized compensation cost (in years)																								3 years 5 months 8 days
Total fair value of stock options vested during period																								40,388	90,000
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated share-based compensation expense			70,430		138,379													3,046	29,800	18,250	39,912	49,134	68,666
Revenues from External Customers [Line Items]
Number of product groups			1
Net product sales			4,904,165		6,313,190			831,462	847,322	51,047	19,266	36,059	7,605	3,763,149	2,819,519	222,448	2,619,478
Summary of accounts payable and accrued liabilities [Abstract]
Accounts payable - suppliers			1,940,492			1,815,369
Accrued commissions			135,905			371,905
Accrued royalties / license fees			707,656			1,028,286
Accrued payroll			211,765			328,564
Accrued vacation			219,280			203,444
Accrued bonuses			0			317,372
Accrued expenses - other			53,371			244,550
TOTAL			$ 3,268,469			$ 4,309,490